Do you want to read an article? Please log in or register.
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
Type 2 Diabetes
COMMENTED
Related content
Type 2 Diabetes
Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database
Diabet Med.
Stoyanova D, Stratmann B, Schwandt A, Heise N, Mühldorfer S, Ziegelasch HJ, Zimmermann A, Tschoepe D, Holl RW, DPV Initiative
doi: 10.1111/dme.13915.
COMMENTED
Type 2 DiabetesGlycemic Control
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ
doi: 10.2337/dci19-0066.
COMMENTED
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
doi: 10.1161/CIR.0000000000000766.
COMMENTED
Glycemic Control
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diabetologia.
Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB
doi: 10.1007/s00125-018-4729-5.
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Diabetes Care.
de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G
doi: 10.2337/dci17-0026.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Circulation.
Rådholm K, Figtree G, Perkovic V, Solomon SD, Mahaffey KW, de Zeeuw D, Fulcher G, Barrett TD, Shaw W, Desai M, Matthews DR, Neal B
doi: 10.1161/
Diabetes - GeneralType 2 Diabetes
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial
Diabetes Care.
Ohkuma T, Jun M, Woodward M, Zoungas S, Cooper ME, Grobbee DE, Hamet P, Mancia G, Williams B, Welsh P, Sattar N, Shaw JE, Rahimi K, Chalmers J; ADVANCE Collaborative Group.
doi: 10.2337/
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians
Ann Intern Med.
Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA; Clinical Guidelines Committee of the American College of Physicians
doi: 10.7326/M17-0939.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
Lancet Diabetes Endocrinol.
Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR
doi: 10.1016/S2213-8587